Morpholino

MO1-dhrs12la

ID
ZDB-MRPHLNO-200720-1
Name
MO1-dhrs12la
Previous Names
  • MO1-dhrs12
  • MO1-flj13639
Target
Sequence
5' - ATGCTGAGTTCCGGTACAGAGACAT - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-dhrs12la
Expressed Gene Anatomy Figures
dhrs12la Fig. 2 with image from Nagarajan et al., 2019
dla Fig. 6 with image from Nagarajan et al., 2019
her4.1 Fig. 6 with image from Nagarajan et al., 2019
mbpa Fig. 4 with image from Nagarajan et al., 2019
notch1a Fig. 6 with image from Nagarajan et al., 2019
plp1b Fig. 4 with image from Nagarajan et al., 2019
Phenotype
Phenotype resulting from MO1-dhrs12la
Phenotype Fish Figures
central nervous system cell population proliferation increased occurrence, abnormal WT + MO1-dhrs12la Fig. 5 with image from Nagarajan et al., 2019
dorsal root ganglion decreased amount, abnormal sb1Tg + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
hindbrain dhrs12la expression absent, abnormal WT + MO1-dhrs12la Fig. 2 with image from Nagarajan et al., 2019
neuron myelin sheath structure, abnormal WT + MO1-dhrs12la Fig. 4 with image from Nagarajan et al., 2019
spinal cord dhrs12la expression absent, abnormal WT + MO1-dhrs12la Fig. 2 with image from Nagarajan et al., 2019
spinal cord ab2-pcna labeling increased amount, abnormal WT + MO1-dhrs12la Fig. 5 with image from Nagarajan et al., 2019
spinal cord GFP expression increased amount, abnormal zf167Tg + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
spinal cord ab3-gfap labeling increased amount, abnormal WT + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
spinal cord astrocyte increased amount, abnormal WT + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
spinal cord cell population proliferation increased occurrence, abnormal WT + MO1-dhrs12la Fig. 5 with image from Nagarajan et al., 2019
spinal cord dorsal side has fewer parts of type oligodendrocyte, abnormal vu12Tg + MO1-dhrs12la Fig. 5 with image,  Fig. 7 from Nagarajan et al., 2019
spinal cord myelin accumulating cell decreased amount, abnormal ue2Tg + MO1-dhrs12la Fig. 4 with image from Nagarajan et al., 2019
spinal cord oligodendrocyte decreased amount, abnormal ue1Tg + MO1-dhrs12la Fig. 4 with image from Nagarajan et al., 2019
swimming decreased process quality, abnormal WT + MO1-dhrs12la Fig. 3 from Nagarajan et al., 2019
swimming behavior decreased occurrence, abnormal WT + MO1-dhrs12la Fig. 3 from Nagarajan et al., 2019
whole organism plp1b expression decreased amount, abnormal WT + MO1-dhrs12la Fig. 4 with image from Nagarajan et al., 2019
whole organism mbpa expression decreased amount, abnormal WT + MO1-dhrs12la Fig. 4 with image from Nagarajan et al., 2019
whole organism dhrs12la expression decreased amount, abnormal WT + MO1-dhrs12la Fig. 2 with image from Nagarajan et al., 2019
whole organism decreased length, abnormal WT + MO1-dhrs12la Fig. 2 with image,  Fig. 7 from Nagarajan et al., 2019
whole organism notch1a expression increased amount, abnormal WT + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
whole organism dla expression increased amount, abnormal WT + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
whole organism her4.1 expression increased amount, abnormal WT + MO1-dhrs12la Fig. 6 with image from Nagarajan et al., 2019
Phenotype of all Fish created by or utilizing MO1-dhrs12la
Phenotype Fish Conditions Figures
whole organism notch1a expression increased amount, abnormal WT + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
whole organism mbpa expression decreased amount, abnormal WT + MO1-dhrs12la control Fig. 4 with image from Nagarajan et al., 2019
whole organism length, ameliorated WT + MO1-dhrs12la chemical treatment by environment: DAPT Fig. 7 from Nagarajan et al., 2019
swimming behavior decreased occurrence, abnormal WT + MO1-dhrs12la control Fig. 3 from Nagarajan et al., 2019
hindbrain dhrs12la expression absent, abnormal WT + MO1-dhrs12la control Fig. 2 with image from Nagarajan et al., 2019
whole organism her4.1 expression increased amount, abnormal WT + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
whole organism decreased length, abnormal WT + MO1-dhrs12la control Fig. 2 with image,  Fig. 7 from Nagarajan et al., 2019
spinal cord cell population proliferation increased occurrence, abnormal WT + MO1-dhrs12la control Fig. 5 with image from Nagarajan et al., 2019
whole organism dla expression increased amount, abnormal WT + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
spinal cord dhrs12la expression absent, abnormal WT + MO1-dhrs12la control Fig. 2 with image from Nagarajan et al., 2019
swimming decreased process quality, abnormal WT + MO1-dhrs12la control Fig. 3 from Nagarajan et al., 2019
spinal cord ab2-pcna labeling increased amount, abnormal WT + MO1-dhrs12la control Fig. 5 with image from Nagarajan et al., 2019
spinal cord ab3-gfap labeling increased amount, abnormal WT + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
central nervous system cell population proliferation increased occurrence, abnormal WT + MO1-dhrs12la control Fig. 5 with image from Nagarajan et al., 2019
whole organism plp1b expression decreased amount, abnormal WT + MO1-dhrs12la control Fig. 4 with image from Nagarajan et al., 2019
whole organism dhrs12la expression decreased amount, abnormal WT + MO1-dhrs12la control Fig. 2 with image from Nagarajan et al., 2019
neuron myelin sheath structure, abnormal WT + MO1-dhrs12la control Fig. 4 with image from Nagarajan et al., 2019
spinal cord astrocyte increased amount, abnormal WT + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
dorsal root ganglion decreased amount, abnormal sb1Tg + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
spinal cord oligodendrocyte decreased amount, abnormal ue1Tg + MO1-dhrs12la control Fig. 4 with image from Nagarajan et al., 2019
spinal cord myelin accumulating cell decreased amount, abnormal ue2Tg + MO1-dhrs12la control Fig. 4 with image from Nagarajan et al., 2019
spinal cord dorsal side altered number of oligodendrocyte, ameliorated vu12Tg + MO1-dhrs12la chemical treatment by environment: DAPT Fig. 7 from Nagarajan et al., 2019
spinal cord dorsal side has fewer parts of type oligodendrocyte, abnormal vu12Tg + MO1-dhrs12la control Fig. 5 with image,  Fig. 7 from Nagarajan et al., 2019
spinal cord GFP expression increased amount, abnormal zf167Tg + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
spinal cord astrocyte increased amount, abnormal zf167Tg + MO1-dhrs12la control Fig. 6 with image from Nagarajan et al., 2019
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.